Borte, M., Melamed, I. R., Pulka, G., Pyringer, B., Knutsen, A. P., Ochs, H. D., . . . Moy, J. N. (2017). Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: A Two-Stage, Multicenter, Prospective, Open-Label Study. J Clin Immunol.
Chicago Style citaatBorte, Michael, et al. "Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients With Primary Immunodeficiency Diseases: A Two-Stage, Multicenter, Prospective, Open-Label Study." J Clin Immunol 2017.
MLA citatieBorte, Michael, et al. "Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients With Primary Immunodeficiency Diseases: A Two-Stage, Multicenter, Prospective, Open-Label Study." J Clin Immunol 2017.